z-logo
open-access-imgOpen Access
ASCO 2019: Metastasiertes Mammakarzinom – erstmals OS-Vorteil mit CDK4/6-Inhibitor plus endokrine Therapie
Publication year - 2019
Publication title -
oncology research and treatment
Language(s) - French
Resource type - Journals
SCImago Journal Rank - 0.553
H-Index - 48
eISSN - 2296-5262
pISSN - 2296-5270
DOI - 10.1159/000503241
Subject(s) - gynecology , medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here